Predicting the effects of supplemental EPA and DHA on the omega-3 index
Author(s) -
Rachel E. Walker,
Kristina Harris Jackson,
Nathan Tintle,
Gregory C. Shearer,
Aldo A. Bernasconi,
Serge Masson,
Roberto Latini,
Bobak Heydari,
Raymond Y. Kwong,
Michael R. Flock,
Penny M. KrisEtherton,
Anne Hedengran,
Robert M. Carney,
Ann C. SkulasRay,
Samuel S. Gidding,
Antonella Dewell,
Christopher D. Gardner,
S. Marlene Gre,
Barbara Sarter,
John W. Newman,
Theresa L. Pedersen,
Mark K. Larson,
William S. Harris
Publication year - 2019
Publication title -
american journal of clinical nutrition
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.608
H-Index - 336
eISSN - 1938-3207
pISSN - 0002-9165
DOI - 10.1093/ajcn/nqz161
Subject(s) - medicine , zoology , triglyceride , placebo , docosahexaenoic acid , population , eicosapentaenoic acid , analysis of variance , fatty acid , mathematics , polyunsaturated fatty acid , chemistry , biology , biochemistry , cholesterol , environmental health , alternative medicine , pathology
Supplemental long-chain omega-3 (n-3) fatty acids (EPA and DHA) raise erythrocyte EPA + DHA [omega-3 index (O3I)] concentrations, but the magnitude or variability of this effect is unclear.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom